GlassScriptPhysician profile
Musa A Wadi
NPI 1760493001
$12,457.79
in general payments reported to CMS, 2019-2025
35 companies · $1,794 in 2025
The $1,794 reported for 2025 was more than what 85% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $1,076 · 2021: $1,853 · 2022: $2,124 · 2023: $2,110 · 2024: $1,659 · 2025: $1,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,370 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,370.18 |
| Education | $191.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,912.05 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,766.68 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Mylan Specialty L.P. | $1,223.94 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $869.54 | 2019-2025 | Ofev |
| Philips North America LLC | $680.67 | 2019-2025 | Vest Therapy Und, (5091) Amd Und, (Bo0) Hosp Vent Devices |
| Genzyme Corporation | $650.42 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $649.97 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $631.00 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $441.68 | 2022-2025 | Tezspire |
| Pfizer INC. | $362.72 | 2019-2025 | |
| United Therapeutics Corporation | $312.03 | 2020-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $182.66 | 2019-2025 | Winrevair |
| Baxter Healthcare | $182.44 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $167.11 | 2021-2025 | Glassia |
| Sunovion Pharmaceuticals INC. | $164.99 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $146.24 | 2019-2025 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $134.38 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $104.32 | 2021-2022 | |
| Allergan, INC. | $101.92 | 2019 | |
| Genentech USA, INC. | $96.47 | 2019-2022 | |
| Insmed, INC. | $91.69 | 2019-2024 | Arikayce |
| Intuitive Surgical, INC. | $88.03 | 2023 | Da Vinci Surgical System |
| Sanofi-Aventis U.S. LLC | $70.37 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $59.32 | 2022 | |
| Viatris Specialty LLC | $54.34 | 2025 | Yupelri |
| Electromed, INC. | $49.81 | 2021-2025 | Smartvest |
| Chiesi USA, INC. | $47.64 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $42.60 | 2019 | |
| Verona Pharma, INC. | $41.30 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $40.57 | 2023-2024 | Inspire |
| 3b Medical, INC. | $22.17 | 2025 | Luna |
| Advanced Respiratory, INC | $21.73 | 2021 | |
| Penumbra, INC. | $19.37 | 2023 | Indigo System |
| Paratek Pharmaceuticals, INC. | $15.32 | 2024 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Musa Wadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.